Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Middle East Healthcare CoSAU:4009 +0.60%79 ROA % is 1.88% as of Mar. 2026, which is 58% below its 10-year median of 4.47. GuruFocus rates SAU:4009 with a GF Score™ of 79/100 and a GF Value™ of ﷼80.23 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Middle East Healthcare Co ranks better than 56.26% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Middle East Healthcare Co's annualizedNet Income for the quarter that ended in Mar. 2026 was ﷼103 Mil.
Middle East Healthcare Co's average Total Assets over the quarter that ended in Mar. 2026 was ﷼5,467 Mil. Therefore, Middle East Healthcare Co's annualized ROA % for the quarter that ended in Mar. 2026 was 1.88%.
The historical rank and industry rank for Middle East Healthcare Co's ROA % or its related term are showing as below:
SAU:4009'
s ROA % Range Over the Past 10 Years
Min: 0.35 Med: 4.47 Max: 16.51
Current: 3.13
During the past 11 years, Middle East Healthcare Co's highest ROA % was 16.51%. The lowest was 0.35%. And the median was 4.47%.
SAU:4009's ROA % is ranked better than 56.26% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 1.85
vs SAU:4009: 3.13
Middle East Healthcare Co (SAU:4009) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Middle East Healthcare Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Healthcare Co ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's ROA % distribution charts can be found below:
* The bar in red indicates where Middle East Healthcare Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Middle East Healthcare Co (SAU:4009) has a ROA % of 1.88% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Middle East Healthcare Co and its competitors. This is 58% below median its historical median of 4.47. Over the past decade, Middle East Healthcare Co's ROA % has ranged from 0.35 to 16.51. According to the industry distribution chart, Middle East Healthcare Co ranks #297 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 43.7%.
Is Middle East Healthcare Co's ROA % too high?
Middle East Healthcare Co's current ROA % of 1.88% is 58% below median its 10-year median of 4.47. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 16.51. The Healthcare Providers & Services industry median ROA % is 1.85. Middle East Healthcare Co's value of 1.88% is 1.6% above this industry median. Based on the distribution chart, Middle East Healthcare Co ranks #297 out of 679 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Middle East Healthcare Co has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Middle East Healthcare Co ranks #297 out of 679 companies for ROA %. This puts Middle East Healthcare Co in the upper half of its industry. The industry median ROA % is 1.85. Middle East Healthcare Co's value of 1.88% is 1.6% above this benchmark. Historically, Middle East Healthcare Co's own ROA % has ranged from 0.35 to 16.51 over the past decade. While the company's 10-year median is 4.47 vs. the industry median of 1.85, Middle East Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.85, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Healthcare Co's current ROA % of 1.88% is 1.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Middle East Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Healthcare Co's current ROA % is 1.88%, which is 58% below median its own 10-year median of 4.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼80.23, compared to a current price of ﷼30.28 — trading 62.3% below its estimated fair value. The current ROA % is 1.88%, which is 58% below median its 10-year median of 4.47 and 1.6% above the Healthcare Providers & Services industry median of 1.85. Middle East Healthcare Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current ROA % is 1.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?
Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued.
The current stock price of ﷼30.28 is trading 62.3% below its estimated GF Value™ of ﷼80.23.
GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4009:
ROA %: 1.88% (58% below median its 10-year median of 4.47)
GF Value™: ﷼80.23 vs. price of ﷼30.28 (62.3% below fair value)
Industry Position: 1.6% above the Healthcare Providers & Services median (#297 of 679)
No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
79GF Score
Get the complete analysis for SAU:4009
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4009 has been successfully added to your 
